ACAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.324980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.104800E-01
Normal-vs-Stage2
1.417810E-01
Normal-vs-Stage3
2.530200E-01
Normal-vs-Stage4
8.201200E-01
Stage1-vs-Stage2
7.192600E-01
Stage1-vs-Stage3
5.573500E-02
Stage1-vs-Stage4
4.716200E-01
Stage2-vs-Stage3
1.103650E-01
Stage2-vs-Stage4
2.329600E-01
Stage3-vs-Stage4
5.830500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.198570E-01
Normal-vs-AfricanAmerican
6.325200E-01
Normal-vs-Asian
1.006200E-01
Caucasian-vs-AfricanAmerican
2.844800E-01
Caucasian-vs-Asian
2.865800E-01
AfricanAmerican-vs-Asian
1.277150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.230790E-01
Normal-vs-Female
1.744830E-01
Male-vs-Female
4.630800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.190000E-01
Normal-vs-Age(41-60Yrs)
3.485800E-01
Normal-vs-Age(61-80Yrs)
9.637600E-02
Normal-vs-Age(81-100Yrs)
3.790200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.741400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.149200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.618800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.707590E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.990100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.627600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.027810E-01
Normal-vs-Daily Drinker
3.499600E-01
Normal-vs-Weekly Drinker
3.865400E-01
Normal-vs-Occasional Drinker
5.180000E-01
Normal-vs-Social Drinker
3.890800E-01
Non Drinker-vs-Daily Drinker
3.985200E-01
Non Drinker-vs-Weekly Drinker
7.187200E-01
Non Drinker-vs-Occasional Drinker
9.645700E-02
Non Drinker-vs-Social Drinker
3.362800E-01
Daily Drinker-vs-Weekly Drinker
6.925400E-01
Daily Drinker-vs-Occasional Drinker
2.336400E-02
Daily Drinker-vs-Social Drinker
1.137630E-01
Weekly Drinker-vs-Occasional Drinker
9.146000E-02
Weekly Drinker-vs-Social Drinker
2.699600E-01
Occasional Drinker-vs-Social Drinker
6.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.455620E-01
Normal-vs-Grade 2
1.171830E-02
Normal-vs-Grade 3
3.049700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.650750E-01
Grade 1-vs-Grade 3
8.699800E-02
Grade 1-vs-Grade 4
1.455620E-01
Grade 2-vs-Grade 3
4.710800E-01
Grade 2-vs-Grade 4
1.171830E-02
Grade 3-vs-Grade 4
3.049700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.795800E-02
Normal-vs-NonDiabetic
7.990300E-02
Diabetic-vs-NonDiabetic
6.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.582600E-01
Normal-vs-NoPancreatitis
9.813800E-02
Pancreatitis-vs-NoPancreatitis
3.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.981000E-01
Normal-vs-N1
1.286580E-01
N0-vs-N1
9.047200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.037200E-01
Normal-vs-TP53-NonMutant
2.338400E-01
TP53-Mutant-vs-TP53-NonMutant
5.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
